Being a cytoprotective agent, the offered Colloidal Silicon Dioxide is extensively supplied to the pharmaceutical companies to make oral gastrointestinal medications, which are primarily for treating active duodenal ulcers. It contains sucrose octa sulfate that varied between 30 to 38% content. In addition, it has a CAS No. as 54182-58-0 with a molecular weight of 2086.70. The provided Sucralfate USP is alternatively called sucrose octakis aluminum complex that comes in an odorless and white powder. Furthermore, this USP formulation is insoluble in water. It basically binds with the ulcer to make a barrier for safeguarding the gastrointestinal tract and prevent mucus degradation.